CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE VS CARFILZOMIB-CYCLOPHOSPHAMIDE-DEXAMETHASONE INDUCTION: PLANNED INTERIM ANALYSIS OF THE RANDOMIZED FORTE TRIAL IN NEWLY DIAGNOSED MULTIPLE MYELOMA

被引：0
|
作者：
Gay, F. [1 ]
Scalabrini, D. Rota [2 ]
Belotti, A. [2 ]
Offidani, M. [2 ]
Tacchetti, P. [2 ]
Petrucci, M. T. [2 ]
Pautasso, C. [1 ]
Palmas, A. D. [2 ]
Siniscalchi, A. [2 ]
Grasso, M. [2 ]
Spadano, A. [2 ]
Giuliani, N. [2 ]
Ballanti, S. [2 ]
Patriarca, F. [2 ]
Canepa, L. [2 ]
Bernardini, A. [1 ]
Aquino, S. [2 ]
Gamberi, B. [2 ]
Zambello, R. [2 ]
Ledda, A. [2 ]
Montefusco, V. [2 ]
Omede, P. [1 ]
Galli, M. [2 ]
Cavo, M. [2 ]
Palumbo, A. [1 ,3 ,4 ]
Musto, P. [2 ]
Boccadoro, M. [1 ]
机构：
[1] Univ Torino, Div Hematol, Myeloma Unit, Turin, Italy
[2] Italian Multiple Myeloma Network, Gimema, Italy
[3] Takeda Pharmaceut Co Employee, Turin, Italy
[4] Takeda Pharmaceut Co, Zurigo, Switzerland
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S410
引用
收藏
页码：143 / 144
页数：2
相关论文
共 50 条
  • [41] Carfilzomib, Lenalidomide, and Dexamethasone In Newly Diagnosed Multiple Myeloma: Initial Results of Phase I/II MMRC Trial
    Jakubowiak, Andrzej J.
    Dytfeld, Dominik
    Jagannath, Sundar
    Vesole, David H.
    Anderson, Tara B.
    Nordgren, Brian K.
    Lebovic, Daniel
    Stockerl-Goldstein, Keith E.
    Griffith, Kent A.
    Hill, Melissa A.
    Harvey, Colleen K.
    Dollard, Akari M.
    Ott, Robert
    Kelley, Susan L.
    Barrickman, Jennifer
    Kauffman, Michael
    Vij, Ravi
    BLOOD, 2010, 116 (21) : 376 - 377
  • [42] A Phase 2 Study of Extended Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Derman, Ben A.
    Major, Ajay
    Rosenblatt, Jacalyn
    Avigan, David
    Rampurwala, Murtuza M.
    Alcantar, Luis
    Libao, Bernadette M.
    McIver, Amanda
    Andreatos, Evangelia
    Major, Sarah
    Wolfe, Brittany
    Gorski, Martha
    Karrison, Theodore G.
    Stefka, Andrew
    Jakubowiak, Andrzej
    BLOOD, 2021, 138
  • [43] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
    Leypoldt, Lisa B.
    Tichy, Diana
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc S.
    Mann, Christoph
    Munder, Markus
    Reinhardt, Hans Christian
    Nogai, Axel
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Zago, Manola
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
  • [44] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone (Isa-KRd) in Patients with High-Risk Newly Diagnosed Multiple Myeloma: Planned Interim Analysis of the GMMG-Concept Trial
    Weisel, Katja
    Besemer, Britta
    Haenel, Mathias
    Lutz, Raphael
    Mann, Christoph
    Munder, Markus
    Goerner, Martin
    Reinhardt, Hans Christian
    Nogai, Axel
    Ko, Yon-Dschun
    De Wit, Maike
    Salwender, Hans
    Scheid, Christoph
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Jauch, Anna
    Zago, Manola
    Benner, Axel
    Tichy, Diana
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Leypoldt, Lisa B.
    BLOOD, 2022, 140 : 1836 - 1838
  • [45] Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
    Dytfeld, Dominik
    Jasielec, Jagoda
    Griffith, Kent A.
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Al-Zoubi, Ammar
    Anderson, Tara
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra
    Jobkar, Terri
    Durecki, Diane E.
    McDonnell, Kathryn
    Mietzel, Melissa
    Couriel, Daniel
    Kaminski, Mark
    Vij, Ravi
    Jakubowiak, Andrzej J.
    HAEMATOLOGICA, 2014, 99 (09) : E162 - E164
  • [46] RAPID AND PERSISTENT EFFICACY OF CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE (KRD) IN AGGRESSIVE MULTIPLE MYELOMA DISEASE
    Garibaldi, B.
    Condorelli, A.
    Romano, A.
    Del Fabro, V.
    Elia, F.
    Di Raimondo, F.
    Conticello, C.
    HAEMATOLOGICA, 2021, 106 (10) : 168 - 169
  • [47] Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI plus ): Interim analysis of an open-label randomised controlled trial
    Jackson, Graham H.
    Pawlyn, Charlotte
    Cairns, David A.
    de Tute, Ruth M.
    Hockaday, Anna
    Collett, Corinne
    Jones, John R.
    Kishore, Bhuvan
    Garg, Mamta
    Williams, Cathy D.
    Karunanithi, Kamaraj
    Lindsay, Jindriska
    Rocci, Alberto
    Snowden, John A.
    Jenner, Matthew W.
    Cook, Gordon
    Russell, Nigel H.
    Drayson, Mark T.
    Gregory, Walter M.
    Kaiser, Martin F.
    Owen, Roger G.
    Davies, Faith E.
    Morgan, Gareth J.
    PLOS MEDICINE, 2021, 18 (01)
  • [48] Phase Ib/II trial of CYKLONE (cyclophosphamide, carfilzomib, thalidomide and dexamethasone) for newly diagnosed myeloma
    Mikhael, Joseph R.
    Reeder, Craig B.
    Libby, Edward N.
    Costa, Luciano J.
    Bergsagel, P. Leif
    Buadi, Francis
    Mayo, Angela
    Reddy, Sravan K. Nagi
    Gano, Katherine
    Dueck, Amylou C.
    Stewart, A. Keith
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (02) : 219 - 227
  • [49] A PHASE I/II TRIAL OF CYCLOPHOSPHAMIDE, CARFILZOMIB, THALIDOMIDE AND DEXAMETHASONE (CYCLONE) IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Mikhael, J.
    Reeder, C.
    Libby, E.
    Costa, L.
    Mayo, A.
    Bergsagel, L.
    Buadi, F.
    Pirooz, N.
    Lubben, J.
    Dueck, A.
    Stewart, A.
    HAEMATOLOGICA, 2012, 97 : 119 - 119
  • [50] Carfilzomib, cyclophosphamide, and dexamethasone in patients with newly diagnosed multiple myeloma: a multicenter, phase 2 study
    Bringhen, Sara
    Petrucci, Maria Teresa
    Larocca, Alessandra
    Conticello, Concetta
    Rossi, Davide
    Magarotto, Valeria
    Musto, Pellegrino
    Boccadifuoco, Luana
    Offidani, Massimo
    Omede, Paola
    Gentilini, Fabiana
    Ciccone, Giovannino
    Benevolo, Giulia
    Genuardi, Mariella
    Montefusco, Vittorio
    Oliva, Stefania
    Caravita, Tommaso
    Tacchetti, Paola
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    BLOOD, 2014, 124 (01) : 63 - 69
12345